Indonesia is the second country with the highest burden of tuberculosis (TB) worldwide after India. The discovery of TB sufferers in Semarang from 2015 to 2020 decreased, primarily due to the Covid19 pandemic since 2019. This study aimed to evaluate pulmonary TB control in health centres to find new patients using a systems approach. The research was conducted within a qualitative analysis. Data collection techniques were in-depth interviews, observation, document review, and focus group discussions. The results show that the Ministry of Health regulations guides TB program policies, the lack of health cadres for detecting TB patients, and the passive and active methods used to detect TB sufferers; there are still shortcomings. The process and planning at the health centre are under the guidelines. The mobilization-implementation of TB patient detection is good enough. Monitoring and evaluation in the detection of TB sufferers have not been going well. In addition, there is a problem with the referral system that is not good in Semarang City. The TB prevention program in detecting pulmonary TB patients in Semarang is running quite well even though the results have not been reached.

Topics
Interviews, Health care, Scholarly publishing, Review
1.
W. H. Organization
,
Global Tuberculosis Report 2017, Genewa
. (
2017
) www.who.int/gho/mortality_burden_disease/cause_death/top10/en/
2.
K.
Lonnroth
,
E.
Jaramillo
,
B. G.
Williams
,
C.
Dye
,
M.
Raviglione
.
Global Tuberculosis control: the role of risk factor and social determinant.
Soc Sci Med.
http://www.sciencedirect.com/science/article/pii/S0277953609002111
3.
Ministry of Health of Republic of Indonesia
, National Stategic Plan of Tuberculosis Control, (
2016
)
4.
Health Profile of Bandarharjo Community Health Centre
(
2019
)
5.
Ministry of Health of Republic of Indonesia
, Regulation on Tuberculosis Prevention No 67/2016 (
2016
)
6.
Ministry of Health of Republic of Indonesia
, Tuberculosis control training modules for health workers (
2017
)
7.
M.
Latifah
,
R. S.
Rahayu
,
F.
Indrawati
.
Correlated factors on performance of tuberculosis program officers at health center in increasing the finding of new afb smear-positive case
,
Unnes Journal of Public Health
,
7
(
1
) :
7
–
13
(
2018
)
https://doi.org/10.15294/ujph.v7i1.16705
Google Scholar
Crossref
Search ADS
 
8.
Stop TB Partnership
. Political Declaration on the Fight Against Tuberculosis. Global Plan to End TB 2018-2022
9.
Z.
Sahile
,
A.
Yared
,
M.
Kaba
.
Patients’experiences and perceptions on associates of TB treatment adherence: a qualitative study on DOTS service in public health centers in Ethiopia
.
BMC Public Health
,
18
(
1
),
462
(
2018
)
https://doi.org/10.1186/s12889-018-5404-y
Google Scholar
Crossref
Search ADS
PubMed
 
10.
G.
Firican
.
How to use the fishbone diagram to determine data quality root causes
, (
2018
)
Google Scholar
 
11.
R. A.
Andreasen
. Marketing social change: Changing behavior to promote health, social development and the environmental.
San Fransisco
:
Jossey-Bass Publishers
(
1995
)
12.
R. P.
Anjanamma
,
Gender differences in treatment outcome of tuberculosis patient under the revised national tubeculosis control programme
,
Int. J. Pharm. Biomed.
4
,
2
,
66
–
68
(
2013
)
Google Scholar
 
13.
G. W.
Comstock
,
V. T.
Livesay
,
D. F.
Woolpert
.
The prognosis of a positive tuberculin reaction in childhood and adolescence.
Am. J. Epidemiol.
99
(
2
),
31
–
38
.
https://doi.org/10.1093/oxfordjournals.aje.a121593
Crossref
Search ADS
 
14.
E.
Broughton
,
S.
Haumba
,
M.
Calnan
 et al
Screening in Maternity to Ascertain Tuberculosis Status (SMATS) study
,
BMC Infectious Disease
,
17
,
191
(
2017
)
https://doi.org/10.1186/s12879-017-2285-0
Google Scholar
Crossref
Search ADS
 
15.
J.
Gomez
.
Tuberculosis Perinatal
,
Elsevier Bol. Med. Hosp. Infant. Mex.
72
,
1
,
61
–
65
(
2015
)
https://doi.org/10.1016/j.bmhimx.2015.01.009
Google Scholar
Crossref
Search ADS
 
16.
M.
Weiner
,
D.
Benator
,
W.
Burman
 et al.
Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
.
Clin. Infect. Dis.
40
(
10
),
1481
–
1491
(
2005
)
https://doi.org/10.1086/429321
Google Scholar
Crossref
Search ADS
PubMed
 
17.
M. F.
Franke
,
M. C.
Becerra
,
D. B.
Tierney
 et al
Counting pyrazinamide in regimens for multidrug-resistant tuberculosis
.
Ann. Am. Thorac. Soc.
12
,
674
–
679
(
2015
)
https://doi.org/10.1513/annalsats.201411-538oc
Google Scholar
Crossref
Search ADS
PubMed
 
18.
Working Group on New TB Drugs
.
The global TB drug pipeline
(
2010
) https://www.newtbdrugs.org/news/2010-working-group-new-tb-drugs-annual-meeting
This content is only available via PDF.
©2023 Authors. Published by AIP Publishing.
2023
Author(s)
You do not currently have access to this content.